Investigating the dysfunction of the cerebral microvasculature in sickle cell disease
Funder: 1. The National Institute of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)Duration: April 2017 - April 2021
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Professor Felicity Gavins Professor - Pharmacology (Principal investigator)
T: +44 (0)1895 267151
E: felicity.gavins@brunel.ac.uk |
+44 (0)1895 267151 | felicity.gavins@brunel.ac.uk | Heinz Wolff 111 |
Outputs
Ansari, J., Senchenkova, EY., Vital, SA., Al-Yafeai, Z., Kaur, G., Sparkenbaugh, E., et al. (2021) 'Targeting AnxA1/Fpr2/ALX Regulates Neutrophil Function Promoting Thrombo-Inflammation Resolution in Sickle Cell Disease'. Blood, 137 (11). pp. 1538 - 1549. ISSN: 0006-4971 Open Access Link
Senchenkova, EY., Ansari, J., Becker, F., Vital, SA., Al-Yafeai, Z., Sparkenbaugh, EM., et al. (2019) 'Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation'. Circulation, 140 (4). pp. 319 - 335. ISSN: 0009-7322 Open Access Link
Senchenkova, EY., Russell, J., Yildirim, A., Granger, DN. and Gavins, FNE. (2019) 'Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II–Induced Microvascular Dysfunction'. Hypertension, 73 (4). pp. 829 - 838. ISSN: 0194-911X Open Access Link